188
Edgemond et al.
isolation of mononuclear cells by one centrifugation, and of granulocytes by com-
bining centrifugation and sedimentation at 1 g. J Clin Lab Invest 21:77–98.
Calignano A, La Rana G, Beltramo M, Makriyannis A, and Piomelli D (1997)
Potentiation of anandamide hypotension by the transport inhibitor, AM404. Eur
J Pharmacol 337: R1–R2.
Callahan KS, Johnson AR, and Campbell WB (1985) Enhancement of the antiaggre-
gatory activity of prostacyclin by propanolol in human platelets. Circulation 71:
1237–1246.
of a cannabinoid receptor and functional expression of the cloned cDNA. Nature
(Lond) 346:561–564.
Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a
peripheral receptor for cannabinoids. Nature (Lond) 365:61–65.
Pfister SL, Schmitz JM, Willerson JT, and Campbell WB (1988) Characterization of
arachidonic acid metabolism in Watanabe heritable hyperlipidemic (WHHL) and
New Zealand White (NZW) rabbit aortas. Prostaglandins 36:515–531.
Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, and Felder CC (1995) Mead
ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and periph-
eral (CB2) cannabinoid receptors. Mol Pharmacol 48:288–292.
Rosolowsky M, Falck JR, and Campbell WB (1996) Metabolism of arachidonic acid by
canine polymorphonuclear leukocytes: synthesis of lipoxygenase and omega-
oxidized metabolites. Biochim Biophys Acta 1300:143–150.
Ryan WJ, Banner WK, Wiley JL, Martin BR, and Razdan RK (1997) Potent anan-
damide analogs: the effect of changing the length and branching of the end pentyl
chain. J Med Chem 40:3617–3625.
Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG,
Compton DR, and Martin BR (1997) Synthesis and pharmacological comparison of
dimethylheptyl and pentyl analogs of anandamide. J Med Chem 40:3626–3634.
Shin DS, Yadagiri P, and Falck JR (1989) Synthesis and structure confirmation of
compound D, a proinflammatory arachidonate metabolite. Tetrahedron Lett 30:
3923–3926.
Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, and Martin BR (1994)
The pharmacological activity of anandamide, a putative endogenous cannabinoid,
in mice. J Pharmacol Exp Ther 270: 219–227.
Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and
Waku K (1995) 2-Arachidonylglycerol: a possible endogenous cannabinoid receptor
ligand in brain. Biochem Biophys Res Commun 215:89–92.
Ueda N, Yamamoto K, Yamamoto S, Tokunaga T, Shirakawa E, Shinkai H, Ogawa
M, Sato T, Kudo I, Inoue K, Takizawa H, Nagano T, Hirobe M, Matsuki N, and
Saito H (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a
cannabinoid receptor agonist. Biochim Biophys Acta 1254:127–134.
Van der Stelt M, Paoletti AM, Maccarrone M, Nieuwenhuizen WF, Bagetta G,
Veldink GA, Agro AF, and Vliegenthart JF. The effect of hydroxylation of linoleoyl
amides on their cannabinomimetic properties. FEBS Lett 415: 313–316 (1997).
Vogel Z, Barg J, Levy R, Saya D, Heldman E, and Mechoulam R (1993) Anandamide,
a brain endogenous compound, interacts specifically with cannabinoid receptors
and inhibits adenylate cyclase. J Neurochem 61:352–355.
Willoughby KA, Moore SF, Martin BR, and Ellis EF (1997) The biodisposition and
metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243–247.
Wise ML, Soderstrom K, Murray TF, and Gerwick WH (1996) Synthesis and can-
nabinoid receptor binding activity of conjugated triene anandamide, a novel eico-
sanoid. Experientia 52:88–92.
Cheng YC and Prusoff WH (1973) Relationship between the inhibition constant (Ki)
and the concentration of inhibitor which causes 50 percent inhibition (I50) of an
enzymatic reaction. Biochem Pharmacol 22:3099–3110.
Das SK, Paria BC, Chakraborty I, and Dey SK (1995) Cannabinoid ligand-receptor
signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332–4336.
Deutsch DG and Chin SA (1993) Enzymatic synthesis and degradation of anandam-
ide, a cannabinoid receptor agonist. Biochem Pharmacol 47: 711–715.
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D,
Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a
brain constituent that binds to the cannabinoid receptor. Science (Washington DC)
258:1946–1949.
Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, and Leon A (1995) Mast
cells express a peripheral cannabinoid receptor with differential sensitivity to
anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376–3380.
Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, and
Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the
human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443–450.
Fretland DJ and Djuric SW (1989) 12(R) And 12(S)-hydroxyeicosatetraenoic acids
stimulate the human polymorphonuclear leukocytes. Prostag Leuko Ess Fatty
Acids 38:215–228.
Fride E and Mechoulam R (1993) Pharmacological activity of the cannabinoid recep-
tor agonist, anandamide, a brain constituent. Eur J Pharmacol 231:313–314.
Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M,
Shire D, Le Fur G, and Casellas P (1995) Expression of central and peripheral
cannabinoid receptors in human immune tissues and leukocyte subpopulations.
Eur J Biochem 232:54–61.
Hampson AJ, Hill WAG, Zan-Phillips M, Makriyannis A, Leung E, Eglen RM, and
Bornheim LM (1995) Anandamide hydroxylation by brain lipoxygenase: metabo-
lite structures and potencies at the cannabinoid receptor. Biochim Biophys Acta
1259:173–179.
Hillard CJ, Edgemond WS, and Campbell WB (1995) Characterization of ligand
binding to the cannabinoid receptor of rat brain membranes using a novel method:
application to anandamide. J Neurochem 64:677–683.
Hillard CJ, Edgemond WS, Jarrahian A, and Campbell WB (1997) Accumulation of
N-arachidonylethanolamine (anandamide) into cerebellar granule cells occurs via
facilitated diffusion. J Neurochem 69:631–638.
Jung G, Yang DC, and Nakao A (1985) Oxygenation of phosphatidylcholine by
human polymorphonuclear leukocyte 15-lipoxygenase. Biochem Biophys Res Com-
mun 130:559–566.
Mackie K, Devane WA, and Hille B (1993) Anandamide, an endogenous cannabinoid,
inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol
Pharmacol 44:498–503.
Yadagiri P, Lumin S, Mosset P, Capdevila J, and Falck JR (1986) Enantiospecific
total synthesis of 8- and 12-hydroxyeicosatetraenoic acid. Tetrahedron Lett 27:
6039–6040.
Yamamoto S (1992) Mammalian lipoxygenases: molecular structures and functions.
Biochim Biophys Acta 1128:117–131.
Manna S, Falck JR, Chacos N, and Capdevila J (1983) Synthesis of arachidonic acid
metabolites produced by purified kidney cortex microsomal cytochrome P-450.
Tetrahedron Lett 24:33–36.
Send reprint requests to: Cecilia J. Hillard, Ph.D., Department of Pharma-
cology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwau-
kee, WI 53226. E-mail: chillard@mcw.edu
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure